Use of SAFARI 2™ as workhorse wire for left-sided structural heart interventions.

Autor: Inanc IH; Kırıkkale Yuksek Ihtisas Hospital, Department of Cardiology, Kırıkkale, Turkey., Mutlu D; Center for Coronary Artery Disease, Minneapolis Heart Institute Foundation, Minneapolis, MN, USA., Marmagkiolis K; University of Texas in Houston, MD Anderson Cancer Center, Houston, TX, USA; Tampa General Hospital, University of South Florida, Tampa, FL, USA., Iliescu C; University of Texas in Houston, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ciliescu@mdanderson.org., Ates I; Department of Cardiology, Yeniyuzyil University Hospital, Istanbul, Turkey., Cilingiroglu M; University of Texas in Houston, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: cilingiroglumehmet@gmail.com.
Jazyk: angličtina
Zdroj: Cardiovascular revascularization medicine : including molecular interventions [Cardiovasc Revasc Med] 2024 Jul; Vol. 64, pp. 21-24. Date of Electronic Publication: 2024 Feb 08.
DOI: 10.1016/j.carrev.2024.02.003
Abstrakt: Background: With the advances in percutaneous treatment technologies, the left atrial appendage occlusion (LAAO) and the transcatheter mitral valve repair using MitraClip (TMVR) are increasingly being performed today. The SAFARI 2™ guidewire is primarily used during transcatheter aortic valve implantation (TAVI), our group has also been using it during MitraClip and LAAO procedures. Our clinical study aimed to share our data on the safety and effectiveness for the use of the SAFARI 2™ guidewire during MitraClip or LAAO procedures.
Methods: This study included a total of 1730 patients (948 patients of MitraClip and 782 of LAAO). It was designed as single arm, retrospective, and multicenter between July 2016 and August 2022. SAFARI 2™ guidewire was used exclusively during all the procedures.
Results: A total of 1730 patients (male 55.8 %) were included in the study. There was no guidewire-related complications, stroke/transient ischemic attack, bleeding (minor/major/life-threatening), need for cardiac surgery, pneumonia, and vascular dissection/rupture in patients undergoing LAAO. There were 2 device-related pericardial effusions without tamponade. No stroke/transient ischemic attack, bleeding (minor/major/life-threatening), mortality, need for cardiac surgery, pneumonia, guidewire-related complication, pericardial effusion, vascular dissection/rupture, or clip embolization was observed in patients undergoing MitraClip.
Conclusions: By taking advantage of its pre-shaped structure, the SAFARI 2™ guidewire seems to offer a reliable and safe device delivery for both MitraClip and LAAO procedures as a regular work horse wire. Our results should be confirmed by larger randomized or prospective trials.
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
(Copyright © 2024. Published by Elsevier Inc.)
Databáze: MEDLINE
Externí odkaz: